Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists.

[1]  L. Nagy,et al.  1,25-Dihydroxyvitamin D3 Is an Autonomous Regulator of the Transcriptional Changes Leading to a Tolerogenic Dendritic Cell Phenotype12 , 2009, The Journal of Immunology.

[2]  G. Vlad,et al.  CD8+ T suppressor cells and the ILT3 master switch. , 2008, Human immunology.

[3]  B. Fedoric,et al.  Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of FoxP3 induction. , 2008, Immunology letters.

[4]  Y. Belkaid,et al.  Review Tuning Microenvironments: Induction of Regulatory T Cells by Dendritic Cells Induction of Foxp3 + Treg Cells by Dcs , 2022 .

[5]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[6]  L. Adorini,et al.  Control of autoimmune diseases by the vitamin D endocrine system , 2008, Nature Clinical Practice Rheumatology.

[7]  U. Švajger,et al.  Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4. , 2008, International immunopharmacology.

[8]  S. Chouaib,et al.  Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34+ Progenitors Promoted by Membrane-Bound IL-15 , 2008, PloS one.

[9]  J. Shiloach,et al.  Retraction: Peritransplant tolerance induction with anti-CD3-immunotoxin: a matter of proinflammatory cytokine control. , 2008, Transplantation.

[10]  C. Daniel,et al.  Immune Modulatory Treatment of Trinitrobenzene Sulfonic Acid Colitis with Calcitriol Is Associated with a Change of a T Helper (Th) 1/Th17 to a Th2 and Regulatory T Cell Profile , 2008, Journal of Pharmacology and Experimental Therapeutics.

[11]  R. Cortesini.  Pancreas cancer and the role of soluble immunoglobulin-like transcript 3 (ILT3). , 2007, JOP : Journal of the pancreas.

[12]  R. Mason,et al.  Topically Applied 1,25-Dihydroxyvitamin D3 Enhances the Suppressive Activity of CD4+CD25+ Cells in the Draining Lymph Nodes1 , 2007, The Journal of Immunology.

[13]  H. Adler,et al.  Tolerogenic dendritic cells in health and disease: friend and foe! , 2007, European journal of dermatology : EJD.

[14]  U. Grohmann,et al.  IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation , 2007, Nature Reviews Immunology.

[15]  R. Steinman,et al.  Taking dendritic cells into medicine , 2007, Nature.

[16]  P. Jensen,et al.  Cutting Edge: Primary B Lymphocytes Preferentially Expand Allogeneic FoxP3+ CD4 T Cells , 2007, The Journal of Immunology.

[17]  M. Battaglia,et al.  Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans , 2007, Nature Reviews Immunology.

[18]  P. Lipsky,et al.  Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation , 2007, The Journal of Immunology.

[19]  A. Thomson,et al.  Tolerogenic dendritic cells and the quest for transplant tolerance , 2007, Nature Reviews Immunology.

[20]  R. Cortesini,et al.  Central role of ILT3 in the T suppressor cell cascade. , 2007, Cellular immunology.

[21]  Zhiliang Wang,et al.  Rapamycin-Conditioned Dendritic Cells Are Poor Stimulators of Allogeneic CD4+ T Cells, but Enrich for Antigen-Specific Foxp3+ T Regulatory Cells and Promote Organ Transplant Tolerance1 , 2007, The Journal of Immunology.

[22]  Alexander H Enk,et al.  Tolerogenic dendritic cells and regulatory T cells: a two-way relationship. , 2007, Journal of dermatological science.

[23]  Erin Nevius,et al.  Peroxisome Proliferator-Activated Receptor γ (PPARγ) and Immunoregulation: Enhancement of Regulatory T Cells through PPARγ-Dependent and -Independent Mechanisms , 2007, The Journal of Immunology.

[24]  U. Grohmann,et al.  Tryptophan catabolism in IDO+ plasmacytoid dendritic cells. , 2007, Current drug metabolism.

[25]  Raquel Hontecillas,et al.  Peroxisome Proliferator-Activated Receptor γ Is Required for Regulatory CD4+ T Cell-Mediated Protection against Colitis , 2007, The Journal of Immunology.

[26]  Junliang Pan,et al.  DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 , 2007, Nature Immunology.

[27]  Shimon Sakaguchi,et al.  Natural regulatory T cells: mechanisms of suppression. , 2007, Trends in molecular medicine.

[28]  T. Klockgether,et al.  Peroxisome Proliferator-Activated Receptor γ Control of Dendritic Cell Function Contributes to Development of CD4+ T Cell Anergy , 2007, The Journal of Immunology.

[29]  L. Adorini,et al.  1,25-Dihydroxyvitamin D3 Selectively Modulates Tolerogenic Properties in Myeloid but Not Plasmacytoid Dendritic Cells1 , 2007, The Journal of Immunology.

[30]  R. Lechler,et al.  Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells. , 2006, International immunopharmacology.

[31]  R. Lechler,et al.  Aspirin‐Treated Human DCs Up‐Regulate ILT‐3 and Induce Hyporesponsiveness and Regulatory Activity in Responder T Cells , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[32]  E. Shevach,et al.  The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells , 2006, Immunological reviews.

[33]  C. Baecher-Allan,et al.  Human regulatory T cells and their role in autoimmune disease , 2006, Immunological reviews.

[34]  E. González-Rey,et al.  Vasoactive Intestinal Peptide , 2006, Annals of the New York Academy of Sciences.

[35]  G. Zhu,et al.  Cutting Edge: Induction of B7-H4 on APCs through IL-10: Novel Suppressive Mode for Regulatory T Cells1 , 2006, The Journal of Immunology.

[36]  S. Ferrari,et al.  Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. , 2006, Blood.

[37]  R. J. Hocking,et al.  Modulation of Dendritic Cell Function by Naive and Regulatory CD4+ T Cells1 , 2006, The Journal of Immunology.

[38]  R. Houot,et al.  Human CD4+CD25high Regulatory T Cells Modulate Myeloid but Not Plasmacytoid Dendritic Cells Activation , 2006, The Journal of Immunology.

[39]  Michael Loran Dustin,et al.  Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo , 2006, The Journal of experimental medicine.

[40]  Y. Belkaid,et al.  CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function , 2005, The Journal of experimental medicine.

[41]  Giuseppe Penna,et al.  Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. , 2005, Blood.

[42]  Yu Wang,et al.  Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus , 2005, Nature.

[43]  R. Lechler,et al.  Everolimus and Basiliximab Permit Suppression by Human CD4+CD25+ Cells in vitro , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[44]  Zhiliang Wang,et al.  Rapamycin‐Treated, Alloantigen‐Pulsed Host Dendritic Cells Induce Ag‐Specific T Cell Regulation and Prolong Graft Survival , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[45]  S. Kim-Schulze,et al.  Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. , 2004, Transplant immunology.

[46]  G. Trinchieri,et al.  Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.

[47]  W. Hörl,et al.  Hyporesponsiveness in Alloreactive T‐cells by NF‐κB Inhibitor‐Treated Dendritic Cells: Resistance to Calcineurin Inhibition , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[48]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[49]  L. Adorini,et al.  A Vitamin D Analog Down-Regulates Proinflammatory Chemokine Production by Pancreatic Islets Inhibiting T Cell Recruitment and Type 1 Diabetes Development1 , 2004, The Journal of Immunology.

[50]  D. Mancini,et al.  Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. , 2004, International immunology.

[51]  M. Karin,et al.  The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .

[52]  L. Adorini,et al.  Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. , 2004, Seminars in immunology.

[53]  M. Sayegh,et al.  The antagonism of calcineurin inhibitors and costimulatory blockers: fact or fiction? , 2004, Transplantation proceedings.

[54]  T. Craig,et al.  Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. , 2003, The Journal of biological chemistry.

[55]  T. Utsugi,et al.  CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. , 2003, Immunity.

[56]  Michel C Nussenzweig,et al.  Tolerogenic dendritic cells. , 2003, Annual review of immunology.

[57]  R. Kumar,et al.  Vitamin D and its analogs as regulators of immune activation and antigen presentation. , 2003, Annual review of nutrition.

[58]  M. Čolić,et al.  Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte‐derived dendritic cells , 2003, Clinical and experimental immunology.

[59]  R. Steinman,et al.  Direct Expansion of Functional CD25+ CD4+ Regulatory T Cells by Antigen-processing Dendritic Cells , 2003, The Journal of experimental medicine.

[60]  D. Mancini,et al.  High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. , 2003, Transplant immunology.

[61]  J. Mudgett,et al.  Antibody‐mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation , 2003, Journal of leukocyte biology.

[62]  Aristides G. Eliopoulos,et al.  Differential Regulation of Vitamin D Receptor and Its Ligand in Human Monocyte-Derived Dendritic Cells1 , 2003, The Journal of Immunology.

[63]  A. Thomson,et al.  Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo. , 2003, Blood.

[64]  Y. Lebranchu,et al.  Effects of immunosuppressive drugs on dendritic cells and tolerance induction , 2003, Transplantation.

[65]  H. Groux,et al.  Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. , 2003, Immunity.

[66]  A. Woltman,et al.  Functional modulation of dendritic cells to suppress adaptive immune responses , 2003, Journal of leukocyte biology.

[67]  L. Adorini,et al.  Cutting Edge: Differential Chemokine Production by Myeloid and Plasmacytoid Dendritic Cells1 , 2002, The Journal of Immunology.

[68]  T. Junt,et al.  β cells are responsible for CXCR3-mediated T-cell infiltration in insulitis , 2002, Nature Medicine.

[69]  P. Jeannesson,et al.  Butyrate affects differentiation, maturation and function of human monocyte‐derived dendritic cells and macrophages , 2002, Clinical and experimental immunology.

[70]  I. Verma,et al.  NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.

[71]  L. Adorini.  1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation. , 2002, Current opinion in investigational drugs.

[72]  A. Enk,et al.  Immature, but not inactive: the tolerogenic function of immature dendritic cells , 2002, Immunology and cell biology.

[73]  R. Kumar,et al.  Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. , 2002, Biochemical and biophysical research communications.

[74]  Gerold Schuler,et al.  Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? , 2002, Trends in immunology.

[75]  C. Mathieu,et al.  Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). , 2002, Diabetes.

[76]  L. Adorini.  Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. , 2002, International immunopharmacology.

[77]  M. Uskoković,et al.  A 1α,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice , 2002 .

[78]  C. Mathieu,et al.  The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents. , 2002, Trends in molecular medicine.

[79]  M. Gilliet,et al.  Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells , 2002, The Journal of experimental medicine.

[80]  David F. Richards,et al.  In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines , 2002, The Journal of experimental medicine.

[81]  M. Colonna,et al.  Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4 , 2002, Nature Immunology.

[82]  Yong‐jun Liu,et al.  Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.

[83]  H. DeLuca,et al.  Vitamin D: its role and uses in immunology 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[84]  J. Thomas,et al.  STEALTH matters: a novel paradigm of durable primate allograft tolerance. , 2001, Immunological reviews.

[85]  J. Thomas,et al.  THIS ARTICLE HAS BEEN RETRACTED

STEALTH matters: a novel paradigm of durable primate allograft tolerance , 2001, Immunological reviews.

[86]  A. Iellem,et al.  Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells , 2001, The Journal of experimental medicine.

[87]  H. Drexhage,et al.  1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. , 2001, European journal of endocrinology.

[88]  P. Mandrekar,et al.  Tacrolimus and Cyclosporine A Inhibit Allostimulatory Capacity and Cytokine Production of Human Myeloid Dendritic Cells , 2001, Journal of Investigative Medicine.

[89]  R. Wood,et al.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line , 2001, BMC Physiology.

[90]  L. Adorini,et al.  Regulatory T Cells Induced by 1α,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance1 , 2001, The Journal of Immunology.

[91]  L. Adorini,et al.  Cutting Edge: Selective Usage of Chemokine Receptors by Plasmacytoid Dendritic Cells1 , 2001, The Journal of Immunology.

[92]  J. D. de Fijter,et al.  Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages. , 2001, Blood.

[93]  M. Ono,et al.  Activating and inhibitory nature of the murine paired immunoglobulin‐like receptor family , 2001, Immunological reviews.

[94]  Simon C Watkins,et al.  Aspirin Inhibits In Vitro Maturation and In Vivo Immunostimulatory Function of Murine Myeloid Dendritic Cells1 , 2001, The Journal of Immunology.

[95]  R. Kumar,et al.  Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[96]  Nina Bhardwaj,et al.  Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[97]  L. Lanier,et al.  Immune inhibitory receptors. , 2000, Science.

[98]  T. Luger,et al.  Mycophenolate Mofetil Impairs the Maturation and Function of Murine Dendritic Cells1 , 2000, The Journal of Immunology.

[99]  R. Matasić,et al.  Cyclooxygenase‐independent inhibition of dendritic cell maturation by aspirin , 2000, Immunology.

[100]  O. Majdic,et al.  1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. , 2000, Experimental hematology.

[101]  A C Allison,et al.  Immunosuppressive drugs: the first 50 years and a glance forward. , 2000, Immunopharmacology.

[102]  P. Allavena,et al.  Vitamin D3 Affects Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells1 , 2000, The Journal of Immunology.

[103]  M. Daha,et al.  The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells , 2000 .

[104]  R. Kumar,et al.  Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. , 2000, Biochemical and biophysical research communications.

[105]  M. Colonna,et al.  A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. , 2000, Seminars in immunology.

[106]  L. Adorini,et al.  1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.

[107]  W. Cook,et al.  Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. , 1999, Transplantation.

[108]  A. Dietz,et al.  Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells , 1999, Journal of leukocyte biology.

[109]  L. Lu,et al.  Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B. , 1999, Transplantation.

[110]  M. Colonna,et al.  A novel family of Ig‐like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells , 1999, Journal of leukocyte biology.

[111]  D. Jarrossay,et al.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.

[112]  P. Allavena,et al.  Glucocorticoids affect human dendritic cell differentiation and maturation. , 1999, Journal of immunology.

[113]  W. V. Berghe,et al.  N-Acetyl-l-Cysteine Inhibits Primary Human T Cell Responses at the Dendritic Cell Level: Association with NF-κB Inhibition , 1999, The Journal of Immunology.

[114]  P. Kalinski,et al.  Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential. , 1998, Journal of immunology.

[115]  W. Yokoyama.  What Goes Up Must Come Down: The Emerging Spectrum of Inhibitory Receptors , 1997, The Journal of experimental medicine.

[116]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[117]  Manfred Brockhaus,et al.  A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing , 1997, The Journal of experimental medicine.

[118]  A. Baldwin,et al.  Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.

[119]  Joseph A. DiDonato,et al.  Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.

[120]  L. Adorini,et al.  The role of IL-12 in the induction of organ-specific autoimmune diseases. , 1995, Immunology today.

[121]  G. Lombardi,et al.  Aspirin and the induction of tolerance by dendritic cells. , 2009, Handbook of experimental pharmacology.

[122]  L. Adorini,et al.  Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. , 2007, Methods in molecular biology.

[123]  P. Morel,et al.  Naturally occurring regulatory T cells: recent insights in health and disease. , 2007, Critical reviews in immunology.

[124]  R. Steinman,et al.  Dendritic cells: translating innate to adaptive immunity. , 2006, Current topics in microbiology and immunology.

[125]  Pau Serra,et al.  Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice , 2006, Nature Immunology.

[126]  Yong‐jun Liu,et al.  IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.

[127]  A. Thomson,et al.  Dendritic cells: emerging pharmacological targets of immunosuppressive drugs , 2004, Nature Reviews Immunology.

[128]  C. Carlberg.  Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[129]  Ranjeny Thomas,et al.  Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. , 2003, Immunity.